Login

Stefanini's Co-Entrepreneurship: Partnering for Value | Estanislau Mendes Llobatera Bassols - CEO of Cielo S.A. 00:10:00

Share On Facebook Share On Twitter

Cielo S.A. Has CEO named Estanislau Mendes Llobatera Bassols

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
humanity has advanced because the remarkable have pushed us forward|Angus Davis,General Partner,Foundation Capital
00:10:00
Q2 2024 Market Insights: Hilltop Wealth Advisors on Inflation, AI, and Fed Strategies - Rusty and Brittany | Hilltop Wealth Advisors
00:10:00
Jim Greig: Representative of Metals Group Inc. | Jim Greig, CEO of Metals Group Inc.
00:10:00
Locust Walk Acquisition Corp Stock Surges 150% Ahead of Merger with Effective Therapeutics
00:10:00
Insights into Cobas AM's Investment in CIR: Perspectives from Iván Chvedine
00:10:00
The Three Emerging Markets Set to Outpace the EU in Global GDP | Jan van Eck, CEO , VanEck .
00:10:00
Ciena CEO Gary Smith delivers a keynote at PTC'18 on embracing change and disruption as industry standards and transformative agents.
00:10:00
Horizon Copper CEO Erfan Kazemi Highlights Strategic Focus on Key Copper Assets, Including Antamina, Oyu Tolgoi, and Hod Maden
00:00:00
Edward M. Hundert, MD Former Dean for Medical Education
00:10:00
Protecting Family Assets Through Limited Partnerships: Insights from Garrett Sutton of Corporate Direct | Garrett Sutton - Asset Protection Expert, Corporate Direct
00:10:00
Arafura Resources' Nolan's Project: Securing Global Supply Chains for Rare Earth Oxides
00:00:00
Fahar Merchant, PhD PRESIDENT AND CHIEF EXECUTIVE OFFICER, Medicenna Therapeutics Corp

© 2017 - Neuhu+